Devices › Gases used within eye to place pressure on detached retina
Device brand name · Intraocular gas
ISPAN Perfluoropropane (C3F8 gas): medical device reports filed with FDA
215 reports name it, 2009–2026. Manufacturer given most often on reports: Airgas Therapeutics. Product code LPO.
- 215
- device reports naming the brand
- 0% of all MAUDE reports · about 12 a year
- 35
- reports, 12 months to August 2026
- 31 in the 12 months before
- 20.9%
- classified as malfunction
- 40.6% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
FDA's MAUDE database holds 215 reports that name the brand "ISPAN Perfluoropropane (C3F8 gas)" (intraocular gas), received between February 2009 and August 2026; the manufacturer given most often on reports is Airgas Therapeutics. Spellings of one product vary from report to report.
35 reports arrived in the 12 months to August 2026, up 13% from 31 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (78.1%), malfunction (20.9%) and other (0.9%); across all gases used within eye to place pressure on detached retina reports (product code LPO) death is recorded in 0% and malfunction in 40.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are gas output problem (2.8%), insufficient device problem information (1.9%) and short fill (1.4%). The patient problems coded most often are intraocular pressure increased, glaucoma and appropriate clinical signs, symptoms and conditions term/code not available. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 508 reports carrying product code LPO. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Gas output problem | 6 | 2.8% | 8.3% |
| Insufficient device problem information | 4 | 1.9% | 5.3% |
| Short fill | 3 | 1.4% | 1.8% |
| Gas/air leak | 2 | 0.9% | 1.8% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Intraocular pressure increasedraised pressure in the eye | 66 | 30.7% |
| Glaucomaraised pressure in the eye | 40 | 18.6% |
| Appropriate clinical signs, symptoms and conditions term/code not available | 30 | 14% |
| Retinal detachmentthe retina separated from the back of the eye | 9 | 4.2% |
| Vitreous floatersfloaters in vision | 4 | 1.9% |
| Cataractclouding of the eye lens | 3 | 1.4% |
| Eye injury | 3 | 1.4% |
| Blurred vision | 2 | 0.9% |
| Conjunctivitispink eye | 2 | 0.9% |
| Corneal clouding/hazing | 2 | 0.9% |
| Corneal edema | 2 | 0.9% |
| Eye burn | 2 | 0.9% |
| Fever | 2 | 0.9% |
| Hyperemia | 2 | 0.9% |
| Inflammationinflammation | 2 | 0.9% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | ISPAN Perfluoropropane (C3F8 gas) | Product code LPO | All MAUDE reports |
|---|---|---|---|
| Reports | 215 | 508 | 26,136,888 |
| Share of that pool | — | 42.3% | 0% |
| Classified as death, per 1,000 reports | 0 | 0 | 9 |
| Classified as injury | 78.1% | 55.9% | 36.2% |
| Classified as malfunction | 20.9% | 40.6% | 62.3% |
| Filed by the manufacturer | 100% | 98.4% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Questions about ISPAN Perfluoropropane (C3F8 gas) reports
How many FDA reports name ISPAN Perfluoropropane (C3F8 gas)?
215 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 35 in the latest 12 months.
What kinds of events are reported?
injury (78.1%), malfunction (20.9%) and other (0.9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
gas output problem (2.8%), insufficient device problem information (1.9%), short fill (1.4%) and gas/air leak (0.9%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that ISPAN Perfluoropropane (C3F8 gas) was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.